Upregulation of osteoclast activity in the development of RA is controlled by osteocytes through the osteoprotegerin/RANKL/RANK (OPG/RANKL/RANK) system (Zhang and Wen, 2021). The gene discussed is TNFRSF11A; the disease is rheumatoid arthritis.